The latest news
AlzeCure Pharma receives positive guidance from the FDA regarding Phase II/III studies with ACD440 in rare disease. Read more.
Aptahome announces that the company's rights issue has been registered and that conversion of BTAs into shares will take place. Read more.
BiBBInstruments enters into an exclusive distribution agreement with TaeWoong Medical USA. Read more.
BioArctic initiates the next step in the phase 2a study of exidavnemab after positive safety evaluation. Read more.
BioInvent presents promising Phase 2a monotherapy data for BI-1808 in CTCL at EHA 2025. Read more.
BioPorto announces that the company has issued warrants. Read more.
Diagonal Cinema reminds that the last day for trading in warrants of series TO 2 is June 16, 2025. Read more.
Multiples portfolio companies Nanologica has received its first order in the USA. Read more.
Genmab has granted employees restricted stock units and warrants. Read more.
Cancer reports positive overall results from the KANDOVA study. Read more.
Lifecare ASA announces that the last day of the exercise period for warrants linked to the rights issue is June 13, 2025. Read more.
Lumito strengthens its Scientific Advisory Board with another key person in connection with the first meeting. Read more.
Magle Chemoswed announces that Magle Group is considering the issuance of senior covered bonds. Read more.
Smell publishes a simplified information document in connection with an upcoming rights issue of shares. Read more.
Nightingale Health draws attention to the fact that the management Minja Salmio and Satu Saksman has been awarded for outstanding leadership. Read more.
Novo Nordisk is moving on to phase III studies with subcutaneous and oral amycretin for weight management. Read more.
Senzime announces that the first tranche of the private placement has been completed. Read more.
SoftOx publishes its financial calendar. Read more.
SOBI presents new clinical data on several hematological diseases at EHA 2025. Read more.
Insider trading & whistleblowing
Genetic Analysis Lifecare Novonesis
Invitations & presentations
Communiqués
CombiGene Scandinavian Real Heart
Summons
Intellego Technologies Observe Medical PharmaLundensis SoftOx Solutions
The latest from BioStock
» New success strengthens Alzinova's licensing opportunities for ALZ-101
» The largest funders and investors in Scandinavian life science
» RFK Jr. appoints new members to vaccine committee
» BioInvent focuses on first-line treatment
» Deep Apple and Novo Nordisk in collaboration on oral drugs
